Ankur Dhingra - 31 May 2022 Form 3 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Financial Officer
Signature
/s/ Ankur Dhingra
Issuer symbol
SMMT
Transactions as of
31 May 2022
Net transactions value
$0
Form type
3
Filing time
02 Jun 2022, 17:38:41 UTC
Previous filing
28 Mar 2022
Next filing
08 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SMMT Common Stock 26,500 31 May 2022 Direct
holding SMMT Common Stock 13,538 31 May 2022 By Dhingra Family Revocable Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney